Solid Biosciences · 8 hours ago
Vice President, Managed Markets
Charlestown-HQ, Charlestown, MA, US
Full-time
Onsite
Director/Executive
$295K/yr - $373K/yr
15+ years expSolid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases. They are seeking a Vice President of Managed Markets to lead the development and execution of the company’s comprehensive U.S. and Global market access strategy.
BiotechnologyGeneticsHealth CareMedical
Responsibilities
Set and lead the overarching managed markets strategy to support pricing, reimbursement, and access objectives across all payer segments
Develop pricing, contracting, and channel strategies to support the launch and lifecycle of Solid Biosciences’ gene therapy products
Design and implement the payer engagement strategy, including development of core access materials, value propositions, and payer advisory initiatives
Build and execute a scalable field access strategy, including definition of field roles, deployment plans, and coordinated messaging with commercial and medical teams
Oversee development of the health economics and outcomes research (HEOR) plan to support the clinical and economic value of Solid Biosciences’ therapies
Partner cross-functionally with Regulatory, Legal, Medical Affairs, Clinical Development, and Commercial to ensure access strategies are aligned with overall business objectives and compliant with relevant laws and regulations
Guide internal and external communications regarding market access and patient support programs
Build and lead a high-performing team, both corporate and field-based, across market access functions
Serve as a key external representative with payers, policy makers, trade organizations, and patient advocacy groups
Qualification
Required
Bachelor's degree in business, public health, life sciences, or related field required
Minimum of 15+ years of experience in market access, pricing, reimbursement, within the biopharmaceutical industry
Strong experience with U.S. and Global payers, distribution models, and specialty product access pathways
Deep knowledge of relevant compliance, legal, and regulatory considerations for market access programs
Experience building and leading high-performing, cross-functional teams in a dynamic environment
Deep understanding of U.S. and Global market access landscape, pricing dynamics, payer systems
Strong strategic thinking and problem-solving skills
Excellent verbal and written communication skills, including the ability to convey complex access and value topics across stakeholder groups
Proven leadership in building and managing cross-functional teams
Ability to influence internal and external stakeholders in a matrixed organization
High level of initiative, accountability, and collaboration
Preferred
Advanced degree (MBA, MPH, PharmD, or equivalent)
Experience in rare disease, gene therapy, or other high-science therapeutic areas
Track record of developing patient-centric support models and payer strategies in preparation for launch
Minimal travel required; travel may include payer meetings, conferences, and internal cross-functional planning
Benefits
Competitive Health and Dental programs with flexible plan offerings, including FSA and HSA programs
401(k) program participation with competitive company matched contributions
Eligibility to participate in Solid’s Employee Stock Purchase Plan
Mobile phone subsidy for eligible employees
Tuition Reimbursement
Vision Coverage
Life Insurance
Voluntary Pet Insurance
Employee Discount Program on Travel, Entertainment, and Services
Employee Assistance Programs
Daily Subsidized Lunch Delivery (onsite @ Hood Park)
Free Onsite Full-Service Gym (onsite @ Hood Park)
Employee Parking (onsite @ Hood Park)
12 Observed Holidays and a winter shut down
15-day PTO Policy and a 40-hour rollover YoY
40-hour Sick Policy
8 Hour Floating Holiday
Company
Solid Biosciences
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
51-200 employees
H1B Sponsorship
Solid Biosciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (3)
2023 (2)
2022 (4)
2021 (2)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$810.3MKey Investors
Ultragenyx PharmaceuticalPerceptive AdvisorsJP Morgan
2025-02-18Post Ipo Equity· $200M
2024-01-08Post Ipo Equity· $109M
2022-09-30Post Ipo Equity· $75M
Leadership Team
Alexander Cumbo
CEO and President
Kevin Tan
Chief Financial Officer
Recent News
Pharmaceutical Technology
2026-01-16
Company data provided by crunchbase